These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4054071)

  • 41. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE; Gow L; Campbell DM; Ogston D
    Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
    van Giezen JJ; Chung-A-Hing JE; Vegter CB; Bouma BN; Jansen JW
    Thromb Haemost; 1994 Dec; 72(6):887-92. PubMed ID: 7740459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
    Rijken DC; de Munk GA; Jie AF
    Thromb Haemost; 1993 Nov; 70(5):867-72. PubMed ID: 8128448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review.
    Sane DC; Pizzo SV; Greenberg CS
    Am J Hematol; 1989 May; 31(1):53-7. PubMed ID: 2495717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elastase digested urokinase (ED-UK).
    Sumi H; Kosugi T; Toki N; Mihara H
    Experientia; 1985 Dec; 41(12):1546-8. PubMed ID: 3852742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid.
    Casslén B; Thorell J; Astedt B
    Contraception; 1981 Apr; 23(4):435-45. PubMed ID: 7023822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat.
    Hagiwara M; Hongo K; Morikawa T
    Jpn J Pharmacol; 1990 Sep; 54(1):86-8. PubMed ID: 2273652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrin-binding urokinase (or precursor form of urokinase) with a molecular weight of about 100,000 in fresh human urine.
    Sumi H; Tsushima H; Maruyama M; Mihara H
    Enzyme; 1985; 34(4):201-11. PubMed ID: 2941273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunochemical studies of high and low molecular forms of urokinase.
    Sumi H; Toki N; Maehara S; Kosugi T; Akazawa K; Matsuo O; Mihara H
    Acta Haematol; 1982; 67(4):263-7. PubMed ID: 6810625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological comparison between human and rat plasminogen activators in blood and the vessel wall.
    Kjaeldgaard A; Larsson B; Astedt B
    J Clin Pathol; 1984 Oct; 37(10):1153-6. PubMed ID: 6541663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue plasminogen activator activity in prostatic cancer.
    Köller A; Kirchheimer J; Pflüger H; Binder BR
    Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depletion of fibrinolysis activators as a result of continuous stress.
    Lyutova LV; Andreenko GV; Karabasova MA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):356-60. PubMed ID: 2465230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Low molecular weight heparin and high and low molecular weight urokinase in fibrinolysis in vivo].
    Badimón L; Villaverde CA; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1979 Dec; 5(3):262-4. PubMed ID: 397803
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of flavone glycosides of Epimedium koreanum on murine fibrinolytic system and apoplectic mortality].
    Shan Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):419-23. PubMed ID: 1303813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunochemical characterization of human plasminogen activators.
    Aasted B
    Biochim Biophys Acta; 1981 May; 668(3):339-48. PubMed ID: 7195285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between tissue plasminogen activator and the activators in blood and vascular wall.
    Rijken DC; Wijngaards G; Welbergen J
    Thromb Res; 1980 Jun; 18(6):815-30. PubMed ID: 7191151
    [No Abstract]   [Full Text] [Related]  

  • 60. Exchange of plasminogen activator between solution and intima.
    Gall W; Gurll NJ; Wright CB; Reynolds DG
    J Surg Res; 1979 May; 26(5):523-7. PubMed ID: 439883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.